Wells Fargo Downgrades Sherwin-Williams (SHW) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Sherwin-Williams (SHW) PT Raised to $580 at UBS
January 31, 2020 6:17 AM ESTUBS analyst John Roberts raised the price target on Sherwin-Williams (NYSE: SHW) to $580.00 (from $570.00) while maintaining a Neutral rating.... More
CFRA Downgrades Sherwin-Williams (SHW) to Hold
January 30, 2020 11:29 AM ESTCFRA downgraded Sherwin-Williams (NYSE: SHW) from Buy to Hold.
For an analyst ratings summary and ratings history on Sherwin-Williams click here. For more ratings news on Sherwin-Williams click here.
Shares of Sherwin-Williams closed at $590.26 yesterday.
... MorePre-Open Stock Movers 1/30: (MGEN) (TLSA) (NOW) Higher (SNDL) (BGG) (TSCO) Lower (more...)
January 30, 2020 9:28 AM ESTToday's Pre-Open Stock Movers
miRagen Therapeutics, Inc. (NASDAQ: MGEN) 27.8% HIGHER; announced new efficacy and safety data from the ATLL arm of its ongoing Phase 1 clinical trial of cobomarsen, which will be presented at the 12th Annual T-Cell Lymphoma Forum in La Jolla, CA, which is taking place from January 30th to February 1st. Of note are the data from the subtype of aggressive ATLL patients who at study... More
Sherwin-Williams (SHW) Misses Q4 EPS and Revs
January 30, 2020 7:08 AM ESTSherwin-Williams (NYSE: SHW) reported Q4 EPS of $4.27, ex-items, $0.12 worse than the analyst estimate of $4.39. Revenue for the quarter came in at $4.11 billion versus the consensus estimate of $4.2 billion.
GUIDANCE:
Sherwin-Williams sees FY2020 EPS of $19.91-$20.71, which may not compare to... More
